FUNDING
The author(s) reported there is no funding associated with the work featured in this article.
Notes
1 If the authors are concerned that ePGT might become a universal clinical screening for all patients, then the moral issues at stake are quite different. Parents are entitled to all other test results for their children. Refusing parents’ access to existing fetal genetic information about their child would require far more robust justification than declining to produce such information in the first place.